Aminocaproic acid
Amicar (aminocaproic acid) is a small molecule pharmaceutical. Aminocaproic acid was first approved as Amicar on 1982-01-01. The pharmaceutical is active against plasminogen. In addition, it is known to target apolipoprotein(a).
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Amicar (generic drugs available since 1987-03-09)
Drug Products
FDA
EMA
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
amicar | New Drug Application | 2020-10-09 |
aminocaproic acid | ANDA | 2023-04-06 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
---|---|
S0017 | Injection, aminocaproic acid, 5 grams |
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | AMINOCAPROIC ACID |
INN | aminocaproic acid |
Description | 6-aminohexanoic acid is an epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator. It has a role as an antifibrinolytic drug, a hematologic agent and a metabolite. It is an epsilon-amino acid and an omega-amino fatty acid. It is functionally related to a hexanoic acid. It is a conjugate acid of a 6-aminohexanoate. It is a tautomer of a 6-aminohexanoic acid zwitterion. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | NCCCCCC(=O)O |
Identifiers
PDB | 3KIV |
CAS-ID | 60-32-2 |
RxCUI | 99 |
ChEMBL ID | CHEMBL1046 |
ChEBI ID | 16586 |
PubChem CID | 564 |
DrugBank | DB00513 |
UNII ID | U6F3787206 (ChemIDplus, GSRS) |
Target
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 5,985 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
118 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more